6681 fundamentals

Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. It offers advanced artificial intelligence technologies and products for the treatment of cognitive impairment diseases which includes brain function information management platform software system, basic cognitive ability test software, cognitive ability auxiliary screening assessment software and dyslexia auxiliary screening assessment software. The company was founded on April 25, 2023 and is headquartered in Shaoxing, China.